<DOC>
	<DOC>NCT03044756</DOC>
	<brief_summary>Omitting the GnRH antagonist on the day of the trigger can be cost effective and more convenient to the women. We will study the impact of omitting the antagonist dose in a prospective randomized trial</brief_summary>
	<brief_title>Omitting GnRH-antagonist Dose on the Day of Ovulation Trigger</brief_title>
	<detailed_description />
	<mesh_term>Pituitary Diseases</mesh_term>
	<criteria>All antagonist cycle ivf who agree to participate expected poor responders.</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>GnRH antagonist</keyword>
	<keyword>Pituitary downregulation</keyword>
	<keyword>IVF</keyword>
	<keyword>ICSI</keyword>
</DOC>